Question

Which is true?

a. The recommened dosing schedule for RBP-6000 is 100mg subcutaneously monthly

b. RBP-6000 is the first approved once- monthly injectable buprenorphine product

c. RBP-6000 should be administered as an IV injection

d. none of the above

Answer 1

Above the question true one is

1.The recommended dosing schedule for RBP6000 is 100mg subcutaneously monthly.    -It is true one because it is treatment of opioid using disorder.

The available dosages are 100mg and 300mg.it is used for prefilled syringes to a health personnel .

First dose will be give RBP -6000 is 300mg for first 2months then followed maintenance dose is RBP-6000 in100mg for monthly once according to clinical condition.

Other options are not true

2. It is not first approved monthly injectable buprenorphine product

3.RBP 6000 is not a IV injection it is only subcutaneous injection

4. Above true one is present